Download TGS TA HSV 1 IgG

Transcript
TGS TA HSV 1 IgG
Sample
1
2
3
REF
Reagents
Lot no.
2
3
2
3
2
3
Average
concentration
(UA/mL)
32.6
36.3
122.1
119.2
225.5
229.2
YB500028
SD
CV %
1.63
1.17
6.13
5.31
13.00
14.97
5.0
3.2
5.0
4.5
5.8
6.5
The reproducibility was calculated by analysing the results of the determination of four sera (one negative
and three positive with differing concentrations of anti-HSV 1 IgG) performed in single replicate, in 16
different sessions, with two lots of reagents.
The concentration of the negative anti-HSV 1 IgG (H1G-N6) serum gave results in the range from 0.4 to 1.0
UA/mL.
The table shows the results obtained with the 3 positive sera.
Sample
Average
concentration
(UA/mL)
SD
(UA/mL)
CV %
1
70.8
5.87
8.3
2
118.0
7.96
6.7
3
215.7
13.39
6.2
Linearity of the Dilutions
The linearity of the TGS TA HSV 1 IgG kit was assessed using a protocol based on the guidelines given in
Clinical and Laboratory Standards (CLSI) document EP6-A.
Serial dilutions, performed by using the System Liquid, of 3 sera with high concentrations of anti-HSV 1 IgG
were dosed.
The results of this study are summed up in the table below.
IFU038TGS TA – Version: 02 – 15 September 2014
Page 11 di 14